The Next Steps For Ultragenyx' Burosumab Following Positive Phase 3 Data
April 19, 2017 at 09:52 AM EDT
Shares of Ultragenyx Pharmaceutical Inc (NASDAQ: RARE), a clinical-stage bio-pharmaceutical company, were trading higher by more than 7 ...